NREP
NEW REPRESENTATIVE AT IB RECEIVED
12/27/2024
Back to search
Official data from USPTO
EYELIGHT
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
50
Latest update
12/27/2024
Classification
Registered
Trademark type
Word
Nice classes
5, 10
Filing date
08/28/2021
Registration date
03/07/2023
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
03/07/2023
Last transaction
11/19/2024
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
CH
Examiner
O'BRIEN, JENNIFER LYNN
Law office
N30
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Galderma Holding SA
Representatives
Katherine P. Califa Foley & Lardner LLP
Technical classification
Nice Classes
Class 5Class 10
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Medicinal preparations based on a dermatological preparation in the nature of medicated dermatological preparations and substancesalone or in kitsincludingbut not limited topre-filled syringesused for filling wrinklesfoldsscarslipsfor face and body contour and skin rejuvenation; medicinal preparations for the treatment of dermatological conditions; non-oral pharmaceutical preparations to treat dermatological conditions; injectable pharmaceutical preparations to treat dermatological conditions; injectable dermal fillersinjectable dermal fillers; pharmaceutical preparations for skin care; muscle relaxants; injectable dermal filler productsinjectable dermal fillers; pharmaceutical preparations for skin care; muscle relaxants
Class 10
Medical devicesimplants consisting of artificial materials in gel formsold alone or in kitsincludingbut not limited topre-filled syringesused for filling wrinklesfoldsscarslipsfor face and body contour and skin rejuvenation; syringes for injections; injection devices for pharmaceutical products
Publications
History of USPTO decisions and trademark events.
50 publications found
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
11/15/2024
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
11/15/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
11/15/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
11/15/2024
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
11/15/2024
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
11/15/2024
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
07/03/2023
FICS
FINAL DISPOSITION NOTICE SENT TO IB
06/09/2023
FIMP
FINAL DISPOSITION PROCESSED
06/09/2023
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
06/07/2023
NREP
NEW REPRESENTATIVE AT IB RECEIVED
03/18/2023
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
03/07/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
03/07/2023
GPNX
NOTIFICATION PROCESSED BY IB
12/21/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
12/20/2022
PUBO
PUBLISHED FOR OPPOSITION
12/20/2022
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
11/30/2022
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
11/30/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
11/30/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
11/14/2022
XAEC
EXAMINER'S AMENDMENT ENTERED
11/05/2022
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
11/05/2022
GNEA
EXAMINERS AMENDMENT E-MAILED
11/05/2022
CNEA
EXAMINERS AMENDMENT -WRITTEN
11/05/2022
LIMN
LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED
10/27/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/03/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/03/2022
ALIE
ASSIGNED TO LIE
10/03/2022
LIMG
LIMITATION OF GOODS RECEIVED FROM IB
09/03/2022
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
08/24/2022
CORN
CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED
08/02/2022
CRCV
CORRECTION TRANSACTION RECEIVED FROM IB
06/11/2022
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
04/16/2022
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
04/04/2022
GNSL
LETTER OF SUSPENSION E-MAILED
04/04/2022
CNSL
SUSPENSION LETTER WRITTEN
04/04/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/07/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/07/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
03/07/2022
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
02/25/2022
RFNT
REFUSAL PROCESSED BY IB
02/06/2022
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
01/18/2022
RFRR
REFUSAL PROCESSED BY MPU
01/18/2022
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
12/25/2021
CNRT
NON-FINAL ACTION WRITTEN
12/24/2021
DOCK
ASSIGNED TO EXAMINER
12/15/2021
MAFR
APPLICATION FILING RECEIPT MAILED
12/03/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
11/29/2021
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
11/25/2021
Continuous trademark protection
Get notified about every new filing that threatens EYELIGHT or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.